Login to Your Account



Other News To Note


Friday, March 1, 2013

• Novan Therapeutics Inc., of Durham, N.C., said in vitro and animal data indicated the firm's SB204, its drug candidate for acne, could lead to a topical treatment to reduce oil production in the skin.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription